![A puzzling case of portal hypertension: a collision between hema- and hepatology | Liver Fellow Network A puzzling case of portal hypertension: a collision between hema- and hepatology | Liver Fellow Network](https://data.liverfellow.org/wp-content/uploads/2021/01/Figure-2.png)
A puzzling case of portal hypertension: a collision between hema- and hepatology | Liver Fellow Network
![Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases | BMC Medicine | Full Text Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases | BMC Medicine | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12916-020-01784-7/MediaObjects/12916_2020_1784_Fig2_HTML.png)
Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases | BMC Medicine | Full Text
![Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study | Gut Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study | Gut](https://gut.bmj.com/content/gutjnl/65/6/1057/F1.large.jpg)
Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study | Gut
![Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma - JHEP Reports Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma - JHEP Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/91a9b775-7f0f-435e-a5c6-56dc20908dd9/fx1_lrg.jpg)
Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma - JHEP Reports
![Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension - ScienceDirect Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827820303688-fx1.jpg)
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension - ScienceDirect
Juan Turnes on Twitter: "2/2 We can use #elastography rule of five + platelet count to identify those with clinically significant portal hypertension: ➡️ >25 kPa ➡️ 20-25 kPa & <150 platelets
![The portal hypertension syndrome: etiology, classification, relevance, and animal models | Semantic Scholar The portal hypertension syndrome: etiology, classification, relevance, and animal models | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/679a5dbe8ad2820e8c8913e219c1cdbec199bb63/2-Figure1-1.png)
The portal hypertension syndrome: etiology, classification, relevance, and animal models | Semantic Scholar
![Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension - JHEP Reports Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension - JHEP Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c0528f6c-57a4-4f99-af1d-e309c26d0325/fx1_lrg.jpg)
Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension - JHEP Reports
PLOS ONE: Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study
![Frontiers | Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis | Medicine Frontiers | Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis | Medicine](https://www.frontiersin.org/files/Articles/803119/fmed-08-803119-HTML/image_m/fmed-08-803119-g001.jpg)
Frontiers | Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis | Medicine
![Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/104af7d5-9690-494e-874c-b7f1ee983513/gr1.jpg)
Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease
![β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6ae13347-e992-42e2-9e38-759b45772734/gr1_lrg.gif)
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet
![Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis - HPB Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis - HPB](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/82383eaa-856d-4177-9f48-d9018e1bffed/gr1.jpg)
Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis - HPB
![Core Concepts - Screening for Varices and Prevention of Bleeding - Management of Cirrhosis-Related Complications - Hepatitis C Online Core Concepts - Screening for Varices and Prevention of Bleeding - Management of Cirrhosis-Related Complications - Hepatitis C Online](https://cdn.hepatitisc.uw.edu/doc/115-4/prognostic-value-hepatic-venous-pressure-gradient-hvpg-persons-chronic-liver-disease.jpg)
Core Concepts - Screening for Varices and Prevention of Bleeding - Management of Cirrhosis-Related Complications - Hepatitis C Online
Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study
![Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension - The Lancet Gastroenterology & Hepatology Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension - The Lancet Gastroenterology & Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9b7b868e-4bb1-4ac1-bb80-3cab1602e78f/gr1_lrg.jpg)